Introduction: Who Should Undergo Diagnostics and When

Color blindness, also known as color vision deficiency, is a condition where people see colors differently than most others. The term “color blindness” is somewhat misleading because most people with this condition can still see colors—they just have difficulty telling certain colors apart. Complete color blindness, where someone sees only shades of gray, is extremely rare.^[1]

Many people with color vision deficiency don’t realize they have it until something brings it to their attention. This is because the symptoms are often mild and people naturally adjust to seeing colors differently throughout their lives. Some individuals only discover their condition when they face confusion distinguishing colors in everyday situations, such as reading color-coded materials or matching clothing.^[2]

Getting tested for color blindness is advisable if you notice certain warning signs. Adults should consider seeking diagnostics if they have trouble telling the difference between certain colors, find it difficult to see how bright colors are, or struggle to distinguish different shades of the same color. These symptoms might seem minor, but they can affect various aspects of daily life.^[1]

Children should be tested if they have a family history of color vision deficiency or if they seem to be having trouble learning colors. Parents might notice their child using the wrong colors when drawing objects, having difficulty reading from color-coded materials like chalkboards, or showing unusual behaviors like smelling food before eating it. Early detection is important because color vision deficiency can make schoolwork challenging, especially when educational materials rely on color coding.^[1]

Certain groups of people face a higher risk for color vision deficiency and should be particularly aware of the need for testing. Men have a much higher risk than women because the most common types of color blindness are genetic conditions passed down on the X chromosome. You’re also more likely to have color vision deficiency if you have certain eye diseases, health problems like diabetes, Alzheimer’s disease, or multiple sclerosis, take certain medications, or are white.^[1]

Adults who suddenly notice changes in how they perceive colors should seek testing promptly. While most color blindness is present from birth, it can also develop later in life due to injuries, diseases, or the natural aging process. Color vision may decline with age, and certain medical conditions carry a higher risk of acquired color blindness. If you notice a change in your color perception, it could be a symptom of a more serious underlying health problem that needs attention.^[1]

Diagnostic Methods

Diagnosing color vision deficiency involves specific tests that help eye care professionals understand how you see colors compared to people with typical color vision. These tests are usually straightforward, non-invasive, and can be completed relatively quickly during a routine eye examination.^[7]

The most common and widely recognized test for color blindness is the Ishihara color test. This test uses specially designed pictures made up of colored dots. Hidden within these dots are numbers or shapes in different colors. If someone has a color vision deficiency, they’ll find it difficult or impossible to see some of the patterns in the dots. People with normal color vision can easily identify the numbers or shapes, while those with color blindness either see different numbers or cannot see any number at all.^[7]

The Ishihara test is particularly effective at detecting red-green color blindness, which is the most common type of color vision deficiency. The test consists of multiple plates, each containing a different pattern. By observing which plates a person can and cannot read correctly, the eye doctor can determine not only whether color blindness is present but also what type it is and how severe it might be.^[3]

Another diagnostic tool used by eye care professionals is the Farnsworth-Munsell 100 Hue Test (often abbreviated as FM-100). This test asks individuals to arrange colored buttons or caps in order by color. The way someone organizes these colors can reveal specific types of color confusion and help measure the severity of the color vision deficiency. This test provides more detailed information than the Ishihara plates and can detect subtle color vision problems that might not show up on simpler screening tests.^[4]

The Hardy-Rand-Rittler test works similarly to the Ishihara test but uses different patterns and color combinations. This test can help identify not just red-green color blindness but also blue-yellow color deficiencies. It’s particularly useful because it can distinguish between different types of color vision problems, giving doctors a more complete picture of how someone perceives colors.^[5]

During a diagnostic appointment, the eye doctor will typically conduct a thorough eye examination before performing color vision tests. This comprehensive approach helps rule out other eye conditions that might be affecting color perception. The doctor will ask about your family history of color blindness, any medications you’re taking, and whether you’ve noticed any recent changes in your vision. This background information helps the doctor interpret the test results more accurately.^[9]

Some eye care professionals use an anomaloscope, which is a more sophisticated instrument for diagnosing color vision deficiency. This device asks the person being tested to match colors by adjusting colored lights. It’s considered one of the most accurate ways to diagnose and classify different types of color blindness, though it’s not as commonly available as the plate tests and requires specialized equipment and training to administer.^[3]

For children, the testing process might be adapted to their age and attention span. Younger children might be given simpler versions of color tests that don’t require them to identify numbers or letters. Instead, they might be asked to trace shapes or identify simple pictures. The key is making the test appropriate for the child’s developmental level while still getting accurate information about their color vision.^[6]

Online color blindness tests are available and can provide a preliminary screening. However, these should not replace a professional evaluation. Computer screens display colors differently, and lighting conditions at home can affect the results. If an online test suggests you might have color vision deficiency, it’s important to follow up with an eye care professional for a proper diagnosis using standardized testing materials under controlled conditions.^[4]

In cases where color blindness develops later in life, additional testing might be necessary to identify the underlying cause. This could include examining the retina (the light-sensitive layer at the back of the eye), checking the optic nerve (which connects the eye to the brain), or even brain imaging if a neurological problem is suspected. Conditions like retinal detachment, eye injuries from lasers, certain brain tumors, or radiation treatment can all lead to acquired color vision deficiency.^[1]

Genetic testing is another option, particularly for families with a history of color blindness or for individuals who want to understand their risk of passing the condition to their children. Since the most common types of color blindness are inherited through genes on the X chromosome, genetic testing can identify whether someone carries the genes responsible for color vision deficiency. This information can be helpful for family planning or understanding the inheritance pattern in a family.^[3]

Diagnostics for Clinical Trial Qualification

Clinical trials exploring treatments for color blindness, particularly those involving gene therapy, require specific diagnostic procedures to determine whether participants qualify for the study. These trials represent cutting-edge research aimed at potentially treating or even curing certain forms of color blindness that have never before had effective treatments available.^[10]

Gene therapy trials for color blindness have been conducted primarily in research settings, with early animal studies showing promising results. Researchers at the University of Washington have developed gene therapy approaches that involve delivering genes to replace missing or faulty color-sensing proteins in cone cells within the retina. These genes are introduced through a single injection into the eye. For someone to participate in such trials, detailed diagnostic testing is essential to confirm they have the specific type of color blindness being studied and that they don’t have other eye conditions that might interfere with the treatment.^[11]

For gene therapy targeting red-green color blindness, researchers need to confirm through diagnostic testing that participants are truly dichromats—meaning they’re missing one type of cone cell entirely—or that they have a significantly non-functioning cone type. Standard color vision tests like the Ishihara plates serve as initial screening tools, but more sophisticated testing is required for clinical trial enrollment. Participants typically undergo comprehensive eye examinations, detailed color vision testing with multiple instruments, and genetic testing to confirm the specific genetic mutation causing their color blindness.^[12]

Clinical trials for achromatopsia, a more severe form of color blindness where people have little or no cone cell function, have made significant progress. These trials require even more detailed baseline testing. Researchers need to measure not only color vision but also visual acuity, light sensitivity, and the presence of other symptoms like involuntary eye movements. Genetic testing is crucial to identify which specific gene mutation is causing the achromatopsia, as the gene therapy must be tailored to address that particular genetic defect.^[12]

Imaging tests of the retina form another important part of clinical trial qualification. Researchers use specialized equipment to photograph and map the retina, ensuring that the cone cells are physically present even if they’re not functioning properly. This is important because gene therapy aims to restore function to existing cells rather than create new ones. If the retinal structure is too damaged or if the cone cells are absent, gene therapy is unlikely to be effective.^[12]

Participants in color vision clinical trials also undergo baseline measurements that will later be compared to post-treatment results. These might include detailed assessments using the Farnsworth-Munsell 100 Hue Test, anomaloscope measurements, and real-world color discrimination tasks. The goal is to establish exactly how the person sees colors before treatment so researchers can accurately measure any improvements afterward.^[4]

Safety screening is another critical component of clinical trial qualification. Because gene therapy involves injecting material directly into the eye, researchers must ensure participants don’t have conditions that would increase the risk of complications. This includes checking for eye infections, inflammation, significant structural abnormalities, or other diseases that affect the eye. General health screening also takes place to identify any medical conditions that might affect healing or increase surgical risks.^[12]

Age requirements and the duration of color blindness are also factors in trial eligibility. Some researchers are interested in studying whether the brain can learn to interpret new color signals if cone function is restored later in life. This relates to questions about neuroplasticity—the brain’s ability to adapt to new information. Diagnostic testing helps researchers understand not just the physical state of someone’s eyes but also how their visual system has developed and adapted to living with color blindness.^[10]

The University of Washington scientists studying gene therapy for color blindness have suggested that treatments may be tested in humans within the near future. Their work, done in collaboration with biotechnology companies, has shown that when genes coding for missing color proteins are delivered to the eyes of colorblind animals, those animals gain the ability to distinguish colors they couldn’t see before. The animals in these studies passed diagnostic tests showing they could now identify colored patterns that were previously invisible to them.^[11]

For individuals interested in participating in clinical trials for color blindness, the first step is typically to undergo standard color vision testing with an eye care professional. If the results suggest they might be eligible for a trial, they would then be referred to the research center conducting the study. The research team would perform additional specialized diagnostic tests to confirm eligibility and establish baseline measurements. It’s important to understand that clinical trials are carefully designed research studies with specific inclusion and exclusion criteria, and not everyone with color blindness will qualify for every trial.^[12]